MainNews

Pfizer CEO Says “Normal Life” Won’t Return Without Regular COVID Vaccinations

“I don’t think that this means that we should be able to live our lives without having vaccinations.”

By Paul Joseph Watson | Summit

The CEO of the pharmaceutical giant Pfizer says that normal life will return within a year, but not for those who don’t have regular COVID-19 vaccinations.

During an appearance on ABC This Week with George Stephanapoulos, Albert Bourla was asked about when he foresaw the end of the pandemic.

Related: The Top Four Reasons Why Many People, Doctors & Scientists Refuse To Take The COVID Vaccine

“Within a year, I think we will be able to come back to normal life,” said Bourla, although he made it very clear that this statement only applies to those who are prepared to take regular coronavirus booster shots.

“I don’t think that this means that variants will not be continuing coming,” Bourla added. “And I don’t think that this means that we should be able to live our lives without having vaccinations, basically.”

Bourla said that the “most likely scenario” was “annual re-vaccinations” due to the emergence of “new variants.”

The Pfizer’s CEO’s comments on annual vaccinations are interesting given that the FDA has so far only approved booster shots for elderly people and “high risk individuals.”

Bourla’s rhetoric is similar to that espoused by Moderna CEO Stephane Bancel, who said last week that even younger people will have to get vaccine booster shots at least once every three years.

This once again underscores how a two tier society is being created where only those who submit to regular shots will be able to enjoy a relatively normal lifestyle.

For those who continue to refuse to be vaccinated, travel, employment and potentially even basic leisure activities will continue to be curtailed, leaving them in a de facto state of lockdown indefinitely.

This article (Pfizer CEO Says “Normal Life” Won’t Return Without Regular COVID Vaccinations) was originally published on Summit and is published under a Creative Commons license.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button